Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet's disease

Inflammatory Bowel Diseases

Volumn 17, Issue 7, 2011, Pages 1594-1602

  Jung, Yoon Suk ^a   Yoon, Jin Young ^a   Lee, Jin Ha ^a   Jeon, Soung Min ^a   Hong, Sung Pil ^a   Kim, Tae Il ^a   Kim, Won Ho ^a   Cheon, Jae Hee ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

intestinal Behcet's disease; prognosis; recurrence; reoperation; surgery

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE DERIVATIVE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTICLE; BEHCET DISEASE; ENTEROPATHY; FEMALE; HIGH RISK PATIENT; HUMAN; INTESTINAL BEHCET DISEASE; INTESTINE PERFORATION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REOPERATION; STEROID THERAPY; SURGICAL PATIENT; TREATMENT OUTCOME;

ADULT; BEHCET SYNDROME; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL PERFORATION; MALE; MEDICAL RECORDS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME; ULCER;

EID: 79958801094     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21517     Document Type: Article

References (36)

1. Kobayashi K, Ueno F, Bito S, et al. Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach. J Gastroenterol. 2007; 42: 737-745. (Pubitemid 47456761)
2. Sakane T, Takeno M, Suzuki N, et al. Behçet's disease. N Engl J Med. 1999; 341: 1284-1291.
3. Kurokawa MS, Suzuki N., Behcet's disease. Clin Exp Med. 2004; 4: 10-20. (Pubitemid 39303587)
4. Dilsen N., History and development of Behçet's disease. Rev Rheum. 1996; 63: 512-519.
5. Bayraktar Y, Ozaslan E, Van Thiel DH., Gastrointestinal manifestations of Behcet's disease. J Clin Gastroenterol. 2000; 30: 144-154. (Pubitemid 30148442)
6. Ebert EC., Gastrointestinal manifestations of Behçet's disease. Dig Dis Sci. 2009; 54: 201-207.
7. Sayek I, Aran O, Uzunalimoglu B, et al. Intestinal Behçet's disease: surgical experience in seven cases. Hepatogastroenterology. 1991; 38: 81-83.
8. Ketch LL, Buerk CA, Liechty D., Surgical implications of Behçet's disease. Arch Surg. 1980; 115: 759-760.
9. Kasahara Y, Tanaka S, Nishino M, et al. Intestinal involvement in Behçet's disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981; 24: 103-106. (Pubitemid 11113357)
10. Iida M, Kobayashi H, Matsumoto T, et al. Postoperative recurrence in patients with intestinal Behçet's disease. Dis Colon Rectum. 1994; 37: 16-21. (Pubitemid 24064264)
11. Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009; 104: 2492-2499.
12. Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behçet's disease. Inflamm Bowel Dis. 2001; 7: 243-249. (Pubitemid 32776518)
13. Kim JS, Lim SH, Choi IJ, et al. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy. 2000; 32: 635-640. (Pubitemid 30458632)
14. Lee KS, Kim SJ, Lee BC, et al. Surgical treatment of intestinal Behçet's disease. Yonsei Med J. 1997; 38: 455-460. (Pubitemid 128516407)
15. Choi IJ, Kim JS, Cha SD, et al. Long-term clinical course and prognostic factors in intestinal Behcet's disease. Dis Colon Rectum. 2000; 43: 692-700. (Pubitemid 30324610)
16. Hur H, Min BS, Kim JS, et al. Patterns of recurrence and prognosis in patients with intestinal Behcet's disease who underwent a bowel resection. J Korean Soc Coloproctol. 2008; 24: 166-174.
17. Cheon JH, Kim WH., Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver. 2007; 1: 118-125.
18. Chung MJ, Cheon JH, Kim SU, et al. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease. J Clin Gastroenterol. 2010; 44: e116-e122.
19. Moon CM, Cheon JH, Shin JK, et al. Prediction of free bowel perforation in patients with intestinal Behcet's disease using clinical and colonoscopic findings. Dig Dis Sci. 2010 [Epub ahead of print].
20. Coskun B, Saral Y, Gdekmerdan A, et al. Activation markers in Behçet's disease. Skinmed. 2005; 4: 282-286.
21. Müftüoǧlu AU, Yazici H, Yurdakul S, et al. Behçet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol. 1986; 25: 235-239. (Pubitemid 16115709)
22. Aydintuǧ AO, Tokgz G, Ozoran K, et al. Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease. Rheumatol Int. 1995; 15: 75-78.
23. Adam B, Calikoglu E., Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. J Eur Acad Dermatol Venereol. 2004; 18: 318-320. (Pubitemid 38618329)
24. Boirivant M, Leoni M, Tariciotti D, et al. The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol. 1988; 10: 401-405.
25. Consigny Y, Modigliani R, Colombel J, et al. A simple biological score for predicting low risk of short-term relapse in Crohn's disease. Inflamm Bowel Dis. 2006; 12: 551-557. (Pubitemid 43977735)
26. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996; 38: 905-910. (Pubitemid 26231777)
27. Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008; 57: 1518-1523.
28. Yamamoto T., Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol. 2005; 11: 3971-3979. (Pubitemid 41235590)
29. Ewe K, Bttger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol. 1999; 11: 277-282. (Pubitemid 29286681)
30. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology. 1999; 116: 294-300. (Pubitemid 29055351)
31. Aberra FN, Lewis JD, Hass D, et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology. 2003; 125: 320-327. (Pubitemid 36929411)
32. Takada Y, Saigenji K., Is intestinal Behcet's disease in fact an enterocolitis or an ulcer disease, and is steroid treatment useful or harmful? J Gastroenterol. 2003; 38: 1015-1016. (Pubitemid 37455794)
33. Aeberhard P, Berchtold W, Riedtmann HJ, et al. Surgical recurrence of perforating and nonperforating Crohn's disease. A study of 101 surgically treated Patients. Dis Colon Rectum. 1996; 39: 80-87. (Pubitemid 26024897)
34. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 1988; 29: 588-592.
35. Baba S, Maruta M, Ando K, et al. Intestinal Behcet's disease: report of five cases. Dis Colon Rectum. 1976; 19: 428-440.
36. Bradbury AW, Milne AA, Murie JA., Surgical aspects of Behcet's disease. Br J Surg. 1994; 81: 1712-1721. (Pubitemid 24372355)